发布日期：2008-3

摘要：

European Markets for Bone Grafts and Bone Cements provides an overview of advancements in the grafting technologies and revenues of the current segments along with a complete analysis of key market drivers, restraints, and trends prevailing in the European market. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: machine bone allografts, standard bone allografts, demineralised bone matrix and bone graft substitutes.

Market Overview
Technological Improvements Reinforce the Case for Allografts in the Bone Grafts and Cements Markets

Traditionally, surgeons have preferred autografts to allografts, as the former takes lesser time to heal and rejuvenate. However, this is set to change with the availability of a wide range of technologically superior bone grafts, which provide surgeons with the flexibility to choose suitable grafts for specific needs. Also, these improved allografts can now be pre-shaped prior to the surgery, considerably reducing the surgery time. End users also prefer allografts for their other significant advantages such as lower hospital and procedure costs, higher success rates, reduced morbidity, pain and blood loss and better stability and rehabilitation.

The rise in the number of published clinical studies substantiating the advantages of allografts has also encouraged surgeons to adopt these grafts. They are further impelled by the availability of machined and standard bone grafts, since unlike autografts, they eliminate the need for an additional surgery. "As manufacturing processes for machined bone become more efficient and are able to extract more value from the same limited supply pool, the number of units sold is expected to increase," says the analyst of this research. "New product designs attract more surgeons and thereby, boost revenues."

Commercial Tissue Companies to Tie up with Non-profit Organisations to Make Organs and Bones Available for Allografts

The bones and organs in allograft surgeries are mainly sourced from donors who pledge their organs. However, with the numbers of donors dwindling or remaining static for almost a decade, there is a crunch in supply of tissues and raw materials for processing. This public reticence to donate organs is due to a variety of reasons such as religious, social and emotional issues as well as inadequate awareness. Moreover, the availability of specific allografts in certain quantities is partly influenced by the number of donations that are processed.

Non-profit organisations have had bigger success than companies in procuring tissues, since relatives feel less queasy about donating a body to a non-profit organisation than selling it to commercial organisations. To counter this situation, commercial companies need to establish agreements with non-profit tissue banks to procure tissue. "Once they collaborate, they could offer high-quality training and education to tissue recovery teams to ensure the donated tissues are collected and refrigerated in time so that there are fewer possibilities of contamination," notes the analyst. "Timely collection of tissues will also improve the testing and screening procedures."

Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:

-Machine bone allografts
-Standard bone allografts
-Demineralised bone matrix
-Bone graft substitutes
图表及目录：

1. Executive Summary
--1. Summary of Major Findings
---1. Summary

-2. Introduction to the European Market for Bone Grafts and Bone Cements
--1. Market Introduction
---1. Introduction
---2. Segmentation

-3. European Market for Bone Grafts and Bone Cements
--1. Total Market Overview
---1. Research Methodology
---2. Market Engineering Measurements
---3. Industry Challenges
---4. Market Drivers
a. Availability of a Wide Range of Bone Grafts and Improved Surgical Technique Provides Surgeons with Greater Flexibility
b. Demographic Factors and the Desire of Active Lifestyle by the Elderly Exhorts the Number of Orthopaedic Procedures
c. Availability of Positive Clinical Studies Increases the Acceptance of Orthobiological Products amongst Surgeons
d. Advantages of Allografts Compared to Autografts are Numerous, Leading to their Acceptance and Revenue Growth
e. Technological Innovations and Introduction of New Methods Increase Market Revenues for Machined Allografts
f. Increasing Number of Spinal Surgeries Boosts the Revenue Growth of Allograft Market
---5. Market Restraints
a. Increased Life Span or Aging Population Decreases the Population of Eligible Donors
b. Fear of Disease Transmission Through Contaminated Allografts Affects the Revenue Growth of the Market
c. Widespread Acceptance of Spinal Cages with Recombinant Human Bone Morphogeneic Protein in Spinal Fusion Poses a Threat to Machined Bone Allografts Market
---6. Revenue Forecasts
---7. Competitive Structure
--2. Machined Bone Allografts Market
---1. Market Overview
---2. Market Engineering Measurements
---3. Revenue Forecasts
---4. Market Share Analysis
--3. Standard Bone Allografts Market
---1. Market Overview
---2. Market Engineering Measurements
---3. Revenue Forecasts
---4. Market Share Analysis
--4. Demineralised Bone Matrix Market
---1. Market Overview
---2. Market Engineering Measurements
---3. Revenue Forecasts
---4. Market Share Analysis
--5. Bone Graft Substitutes Market
---1. Market Overview
---2. Market Engineering Measurements
---3. Revenue Forecasts
---4. Market Share Analysis
--6. Bone Cements Market
---1. Market Overview
---2. Market Engineering Measurements
---3. Revenue Forecasts
---4. Market Share Analysis
--7. Strategic Recommendations
---1. Strategic Recommendations for the European Bone Grafts and Bone Cements Market

-4. Geographic Analysis of the European Market for Bone Grafts and Bone Cements
--1. Analysis of the German Market for Bone Grafts and Bone Cements
---1. Introduction to German Healthcare System
---2. Market Engineering Measurements
---3. Market Trends and Revenue Forecasts
--2. Analysis of the French Market for Bone Grafts and Bone Cements
---1. Introduction to French Healthcare System
---2. Market Engineering Measurements
---3. Market Trends and Revenue Forecasts
--3. Analysis of the U.K Market for Bone Grafts and Bone Cements
---1. Introduction to U.K Healthcare System
---2. Market Engineering Measurements
---3. Market Trends and Revenue Forecasts
--4. Analysis of the Italian Market for Bone Grafts and Bone Cements
---1. Introduction to Italian Healthcare System
---2. Market Engineering Measurements
---3. Market Trends and Revenue Forecasts
--5. Analysis of the Spanish Market for Bone Grafts and Bone Cements
---1. Introduction to Spanish Healthcare System
---2. Market Engineering Measurements
---3. Market Trends and Revenue Forecasts
--6. Analysis of the Scandinavian Market for Bone Grafts and Bone Cements
---1. Introduction to Scandinavian Healthcare System
---2. Market Engineering Measurements
---3. Market Trends and Revenue Forecasts
--7. Analysis of the Benelux Market for Bone Grafts and Bone Cements
---1. Introduction to Benelux Healthcare System
---2. Market Engineering Measurements
---3. Market Trends and Revenue Forecasts

-5. Key Industry Participants
--1. Industry Participants
---1. List of Key Industry Participants

-6. Decision Support Database
--1. Healthcare Expenditure
---1. Government Healthcare Expenditure
---2. Private Healthcare Expenditure
---3. Total Healthcare Expenditure
---4. Percentage of Healthcare Expenditure
--2. Healthcare Infrastructure
---1. Number of Specialised Practitioners

List of Figures

Chapter 3

Bone Grafts and Bone Cements Market: Impact of Top Four Industry Challenges (Europe), 2008-2014
Bone Grafts and Bone Cements Market: Market Drivers Ranked in Order of Impact (Europe), 2008-2014
Bone Grafts and Bone Cements Market: Market Restraints Ranked in Order of Impact (Europe), 2008-2014
Bone Grafts and Bone Cements Market: Revenue Forecasts (Europe), 2004-2014
Bone Grafts and Bone Cements Market: Competitive Structure (Europe), 2007
Machined Bone Allografts Market: Revenue Forecasts (Europe), 2004-2014
Machined Bone Allografts Market: Company Market Share by Revenues (Europe), 2007
Standard Bone Allografts Market: Revenue Forecasts (Europe), 2004-2014
Standard Bone Allografts Market: Company Market Share by Revenues (Europe), 2007
Demineralised Bone Matrix Market: Revenue Forecasts (Europe), 2004-2014
Demineralised Bone Matrix Market: Company Market Share by Revenues (Europe), 2007
Bone Graft Substitutes Market: Revenue Forecasts (Europe), 2004-2014
Bone Graft Substitutes Market: Company Market Share by Revenues (Europe), 2007
Bone Cements Market: Revenue Forecasts (Europe), 2004-2014
Bone Cements Market: Company Market Share by Revenues (Europe), 2007

Chapter 4

Bone Grafts and Bone Cements Market: Revenue Forecasts (Germany), 2004-2014
Machined Bone Allografts Market: Revenue Forecasts (Germany), 2004-2014
Standard Bone Allografts Market: Revenue Forecasts (Germany), 2004-2014
Demineralised Bone Matrix Market: Revenue Forecasts (Germany), 2004-2014
Bone Graft Substitutes Market: Revenue Forecasts (Germany), 2004-2014
Bone Cements Market: Revenue Forecasts (Germany), 2004-2014
Bone Grafts and Bone Cements Market: Revenue Forecasts (France), 2004-2014
Machined Bone Allografts Market: Revenue Forecasts (France), 2004-2014
Standard Bone Allografts Market: Revenue Forecasts (France), 2004-2014
Demineralised Bone Matrix Market: Revenue Forecasts (France), 2004-2014
Bone Graft Substitutes Market: Revenue Forecasts (France), 2004-2014
Bone Cements Market: Revenue Forecasts (France), 2004-2014
Bone Grafts and Bone Cements Market: Revenue Forecasts (U.K), 2004-2014
Machined Bone Allografts Market: Revenue Forecasts (U.K), 2004-2014
Standard Bone Allografts Market: Revenue Forecasts (U.K), 2004-2014
Demineralised Bone Matrix Market: Revenue Forecasts (U.K), 2004-2014
Bone Graft Substitutes Market: Revenue Forecasts (U.K), 2004-2014
Bone Cements Market: Revenue Forecasts (U.K), 2004-2014
Bone Grafts and Bone Cements Market: Revenue Forecasts (Italy), 2004-2014
Machined Bone Allografts Market: Revenue Forecasts (Italy), 2004-2014
Standard Bone Allografts Market: Revenue Forecasts (Italy), 2004-2014
Demineralised Bone Matrix Market: Revenue Forecasts (Italy), 2004-2014
Bone Graft Substitutes Market: Revenue Forecasts (Italy), 2004-2014
Bone Cements Market: Revenue Forecasts (Italy), 2004-2014
Bone Grafts and Bone Cements Market: Revenue Forecasts (Spain), 2004-2014
Machined Bone Allografts Market: Revenue Forecasts (Spain), 2004-2014
Standard Bone Allografts Market: Revenue Forecasts (Spain), 2004-2014
Demineralised Bone Matrix Market: Revenue Forecasts (Spain), 2004-2014
Bone Graft Substitutes Market: Revenue Forecasts (Spain), 2004-2014
Bone Cements Market: Revenue Forecasts (Spain), 2004-2014
Bone Grafts and Bone Cements Market: Revenue Forecasts (Scandinavia), 2004-2014
Machined Bone Allografts Market: Revenue Forecasts (Scandinavia), 2004-2014
Standard Bone Allografts Market: Revenue Forecasts (Scandinavia), 2004-2014
Demineralised Bone Matrix Market: Revenue Forecasts (Scandinavia), 2004-2014
Bone Graft Substitutes Market: Revenue Forecasts (Scandinavia), 2004-2014
Bone Cements Market: Revenue Forecasts (Scandinavia), 2004-2014
Bone Grafts and Bone Cements Market: Revenue Forecasts (Benelux), 2004-2014
Machined Bone Allografts Market: Revenue Forecasts (Benelux), 2004-2014
Standard Bone Allografts Market: Revenue Forecasts (Benelux), 2004-2014
Demineralised Bone Matrix Market: Revenue Forecasts (Benelux), 2004-2014
Bone Graft Substitutes Market: Revenue Forecasts (Benelux), 2004-2014
Bone Cements Market: Revenue Forecasts (Benelux), 2004-2014

Chapter 6

Decision Support Database: Government Healthcare Expenditure in Billion USD (World), 2002-2012
Decision Support Database: Private Healthcare Expenditure in Billion USD (World), 2002-2012
Decision Support Database: Total Healthcare Expenditure in Billion USD (World), 2002-2012
Decision Support Database: Percent of Healthcare Expenditure in GDP (World), 2002-2012
Decision Support Database: Number of Specialized Practitioners in '000 (World), 2002-2012